Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy

NACompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions

Stomach Cancer

Interventions

DRUG

Mosapride citrate

Patients receive mosapride citrate (5mg/T) three times a day from the first day after surgery.

DRUG

Placebo

Trial Locations (1)

GangnamSeverance Hospital, Seoul

All Listed Sponsors

lead

Gangnam Severance Hospital

OTHER

NCT04493125 - Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy | Biotech Hunter | Biotech Hunter